Ovarian cancer is one of the leading causes of death from gynecologic origin. The diagnosis is often obtained at advanced stage disease and even if an optimal debulking is achieved almost 2/3 of patients develop a recurrence.
Hyperthermic intraperitoneal chemotherapy (HIPEC) for ovarian cancer recurrence: systematic review and meta-analysis
The series “Ovarian Cancer Recurrence” was commissioned by the editorial office, Gland Surgery without any sponsorship or funding. Dr. Stefano Cianci served as the unpaid Guest Editor for the series.